Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
giuseppe.pugliese@uniroma1.it
Giuseppe Pugliese
Professore Ordinario
Struttura:
DIPARTIMENTO DI MEDICINA CLINICA E MOLECOLARE
E-mail:
giuseppe.pugliese@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
The Quality of Life of Thalassemic Patients: The Role of Endocrine Defect Compensation
ENDOCRINE, METABOLIC & IMMUNE DISORDERS DRUG TARGETS
2021
L-carnosine and its derivatives as new therapeutic agents for the prevention and treatment of vascular complications of diabetes
CURRENT MEDICINAL CHEMISTRY
2020
Association between on-treatment haemoglobin A1c and all-cause mortality in individuals with type 2 diabetes: importance of personalized goals and type of anti-hyperglycaemic treatment
JOURNAL OF CLINICAL MEDICINE
2020
Sedentariness and urinary metabolite profile in type 2 Diabetic Patients, a cross-sectional study
METABOLITES
2020
New Insights and methods in the approach to Thalassemia Major. The lesson From the case of adrenal insufficiency
FRONTIERS IN MOLECULAR BIOSCIENCES
2020
Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes. a prospective cohort study
BMJ OPEN DIABETES RESEARCH AND CARE
2020
The inflammasome in chronic complications of diabetes and related metabolic disorders
CELLS
2020
Diabetes promotes invasive pancreatic cancer by increasing systemic and tumour carbonyl stress in Kras G12D/+mice
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
2020
Indications for renal biopsy in patients with diabetes. Joint position statement of the Italian Society of Nephrology and the Italian Diabetes Society
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
2020
Galectin-3 gene deletion results in defective adipose tissue maturation and impaired insulin sensitivity and glucose homeostasis
SCIENTIFIC REPORTS
2020
Renal protection with glucagon-like peptide-1 receptor agonists
CURRENT OPINION IN PHARMACOLOGY
2020
Is diabetes mellitus a risk factor for COronaVIrus Disease 19 (COVID-19)?
ACTA DIABETOLOGICA
2020
Cardiovascular Outcomes with Ertugliflozin in Type 2 Diabetes
NEW ENGLAND JOURNAL OF MEDICINE
2020
Metabolically healthy versus metabolically unhealthy obesity
METABOLISM, CLINICAL AND EXPERIMENTAL
2019
Effect of a Behavioral Intervention Strategy on Sustained Change in Physical Activity and Sedentary Behavior in Patients with Type 2 Diabetes. The IDES-2 Randomized Clinical Trial
JAMA
2019
Management of diabetes mellitus in patients undergoing liver transplantation
PHARMACOLOGICAL RESEARCH
2019
Central role of the β-cell in driving regression of diabetes after liver transplantation in cirrhotic patients
JOURNAL OF HEPATOLOGY
2019
Is resistant hypertension an independent predictor of all-cause mortality in individuals with type 2 diabetes? A prospective cohort study
BMC MEDICINE
2019
Diabetic kidney disease. new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "the natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function"
NMCD. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
2019
Diabetic kidney disease. new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function"
JN. JOURNAL OF NEPHROLOGY
2019
« prima
< precedente
1
2
3
4
5
6
seguente ›
ultima »
Progetti di Ricerca
MicroRNAs as biomarkers of all-cause mortality and major acute cardiovascular events in patients with type 2 diabetes
Gruppi di ricerca
Slowly progressive autoimmune diabetes: a clinical model for novel pathways of ß-cell protection
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma